Published • loading... • Updated
Diabetes Drug Face-Off: New Japanese Trial Tests Whether a Popular SGLT2
Summary by BIOENGINEER.ORG
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.1 Articles
1 Articles
Diabetes Drug Face-Off: New Japanese Trial Tests Whether a Popular SGLT2
A large share of Japanese patients living with type 2 diabetes are older adults who are not obese, a population that has been largely invisible in the international evidence base for one of the fastest-growing classes of diabetes drugs. Now, a team of researchers led by Yasutaka Takeda and Naoki Kumashiro of Kanazawa Medical University […]
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
